Search for a command to run...
Sai Life Sciences Ltd. exhibits moderate growth potential but lags behind peers in profitability and valuation metrics. Key competitors such as Cipla and Dr. Reddy's showcase superior profitability, while companies like Divi's Laboratories reveal concerning growth metrics. The sector presents a mix of strong performers and some potential value opportunities, particularly in firms with low PEG ratios but strong margins.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
SAILIFE | ₹845.05 | ₹17,612.03Cr | 101.74 | 15.53% | 0.06 |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |